Izzy Ahmad

Role: Mirum Pharmaceuticals, Inc.
Location: Alameda, CA, US
LinkedIn followers: 500 followers

OtherView LinkedIn profile

About Izzy Ahmad

Experienced, skilled, and dedicated Senior Desktop Support professional with twenty years…

Experience

Mirum Pharmaceuticals, Inc.
Present

Education

Joliet West High
High School Diploma

Skills

Remedy
IT Operations
Firewalls
Computer Hardware Troubleshooting
Ms Office Suite
Antivirus
Hardware Support
A+ Certified
Vnc
Wap
Sla
Printers
Active Directory
As400 Administration
Crm Software
Call Center
Proprietary Software
Windows 8.1
Laptops
Cisco Wireless
Desktop Support
Onboarding
Bmc Remedy
Large Scale Deployments
Microsoft Outlook
Windows Xp
Software Installation
Routers
Service-Now.com
Technical Support
Data Migration
Backup Solutions
Ping
Casper
Sccm
Itil
As400
Telephony
Os X
Windows10

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@mirumpharma.com
Personal email
•••••@•••••.com
Direct dial
+16•••••••05

Unlock verified contacts

Free to start · No credit card required

Current company

Mirum Pharmaceuticals, Inc.

Pharmaceutical Manufacturing · 496 employees · Founded 2018 · Foster City, California, United States

Mirum Pharmaceuticals is a leading rare disease company with a global footprint of approved products and a broad pipeline of investigational medicines. Purpose-built to bring forward breakthrough medicines for people with overlooked conditions, Mirum combines deep rare disease expertise with strong connections to patient communities. The company’s commercial portfolio includes LIVMARLI® (maralixibat) for Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC), CHOLBAM® (cholic acid) for bile-acid synthesis disorders, and CTEXLI® (chenodiol) for cerebrotendinous xanthomatosis (CTX). Mirum’s clinical-stage pipeline includes volixibat, an IBAT inhibitor in late-stage development for primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC), brelovitug, a fully human monoclonal antibody in late-stage development for chronic hepatitis delta virus (HDV) and MRM-3379, a PDE4D inhibitor being evaluated for Fragile X syndrome (FXS). Mirum’s success is driven by a team dedicated to advancing high impact medicines through strategic development, disciplined execution and purposeful collaboration across the rare disease ecosystem. Learn more at www.mirumpharma.com.

mirumpharma.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Izzy Ahmad

Experience

Education

Joliet West High

Skills

Find verified contacts for anyone on LinkedIn